PLATINUM INVESTMENT MANAGEMENT LTD
Reported holdings as of Q2 2026, from 31 quarterly filings.
Holdings
| Security | Ticker | Value | Shares | Weight | Weight change | Held | Change |
|---|---|---|---|---|---|---|---|
| ZTO EXPRESS CAYMAN INC | ZTO | $44.6M | 1,994,127 | -1.68pp | 31q | HELD | |
| MICRON TECHNOLOGY INC | MU | $20.5M | 17,782 | +3.03pp | 31q | -24.8%-$6.8M | |
| LAM RESEARCH CORP | LRCX | $20.1M | 46,439 | +2.45pp | 7q | HELD | |
| TRIP COM GROUP LTD | TCOM | $14.0M | 351,921 | -1.32pp | 27q | -7.3%-$1.1M | |
| DINGDONG CAYMAN LTD | DDL | $12.5M | 6,486,507 | -1.12pp | 18q | HELD | |
| NOAH HLDGS LTD | NOAH | $9.9M | 993,612 | -0.04pp | 28q | HELD | |
| BROADCOM INC | AVGO | $9.9M | 26,186 | +0.39pp | 11q | HELD | |
| BIRKENSTOCK HOLDING PLC | BIRK | $9.0M | 210,000 | -0.26pp | 8q | -23.6%-$2.8M | |
| ASTRAZENECA PLC | AZN | $9.0M | 48,088 | -0.14pp | 2q | HELD | |
| ALPHABET INC | GOOG | $8.7M | 24,592 | +0.36pp | 31q | HELD | |
| MERCK & CO INC | MRK | $8.1M | 63,316 | +0.08pp | 6q | HELD | |
| APOGEE THERAPEUTICS INC | APGE | $7.7M | 58,314 | +0.67pp | 12q | HELD | |
| ABBVIE INC | ABBV | $7.6M | 30,102 | +0.21pp | 6q | HELD | |
| JOHNSON & JOHNSON | JNJ | $7.1M | 27,830 | +0.02pp | 13q | HELD | |
| YUM BRANDS INC | YUM | $6.4M | 39,847 | flat | 5q | HELD | |
| PDD HOLDINGS INC | PDD | $6.0M | 78,445 | -0.55pp | 14q | HELD | |
| COGENT BIOSCIENCES INC | COGT | $6.0M | 154,220 | +0.38pp | 23q | +37.6%+$1.6M | |
| UBS GROUP AG | UBS | $5.8M | 117,507 | +0.30pp | 6q | HELD | |
| NVIDIA CORPORATION | NVDA | $5.6M | 28,191 | +0.15pp | 13q | HELD | |
| IMMUNOVANT INC | IMVT | $5.6M | 144,671 | +0.23pp | 20q | -20.4%-$1.4M | |
| ARROWHEAD PHARMACEUTICALS IN | ARWR | $5.3M | 64,752 | +0.27pp | 14q | HELD | |
| IDEAYA BIOSCIENCES INC | IDYA | $5.2M | 138,708 | +0.50pp | 24q | +51.4%+$1.8M | |
| IQVIA HLDGS INC | IQV | $5.2M | 26,708 | +0.12pp | 5q | HELD | |
| H WORLD GROUP LTD | HTHT | $4.9M | 117,996 | -0.29pp | 26q | HELD | |
| VERA THERAPEUTICS INC | VERA | $4.9M | 113,687 | +0.05pp | 13q | HELD | |
| STRUCTURE THERAPEUTICS INC | GPCR | $4.8M | 90,363 | +0.38pp | 14q | +35.1%+$1.3M | |
| VISA INC | V | $4.8M | 14,000 | +0.04pp | 11q | -6.7%-$343.1K | |
| CATERPILLAR INC | CAT | $4.8M | 4,500 | -0.34pp | 3q | -47.1%-$4.3M | |
| ROGERS COMMUNICATIONS INC | RCI | $4.8M | 147,160 | -0.24pp | 5q | HELD | |
| AMER SPORTS INC | AS | $4.7M | 140,000 | -0.08pp | 8q | -6.7%-$338.4K | |
| KROGER CO | KR | $4.5M | 81,305 | flat | 4q | +33.9%+$1.1M | |
| KLA CORP | KLAC | $4.4M | 14,580 | +0.54pp | 5q | +900.0%+$4.0M | |
| CAMECO CORP | CCJ | $4.3M | 42,356 | -0.10pp | 16q | HELD | |
| ADVANCED MICRO DEVICES INC | AMD | $4.2M | 7,210 | +0.66pp | 3q | HELD | |
| ARCUS BIOSCIENCES INC | RCUS | $4.1M | 134,217 | +0.29pp | 31q | HELD | |
| ADOBE INC | ADBE | $3.8M | 18,571 | -0.20pp | 6q | HELD | |
| FLOOR & DECOR HLDGS INC | FND | $3.7M | 62,500 | +0.05pp | 4q | -7.4%-$296.8K | |
| META PLATFORMS INC | META | $3.7M | 6,500 | +0.18pp | 31q | +30.0%+$844.9K | |
| PALISADE BIO INC | PALI | $3.6M | 1,730,866 | +0.35pp | 3q | +40.6%+$1.0M | |
| DUTCH BROS INC | BROS | $3.6M | 50,000 | +0.21pp | 4q | -4.8%-$179.5K | |
| FAIR ISAAC CORP | FICO | $3.6M | 3,000 | -0.03pp | 4q | -11.8%-$477.9K | |
| GE VERNOVA INC | GEV | $3.6M | 3,047 | +0.21pp | 3q | HELD | |
| HOME DEPOT INC | HD | $3.5M | 10,000 | -0.09pp | 4q | -13.0%-$529.0K | |
| VALARIS LTD | VAL | $3.3M | 45,956 | -0.32pp | 14q | HELD | |
| E L F BEAUTY INC | ELF | $3.3M | 45,000 | -0.29pp | 7q | -37.9%-$2.0M | |
| CAVA GROUP INC | CAVA | $3.3M | 42,000 | -0.11pp | 3q | -6.7%-$235.4K | |
| DEFINIUM THERAPEUTICS INC | DFTX | $3.3M | 70,000 | +0.48pp | 2q | HELD | |
| ROIVANT SCIENCES LTD | ROIV | $3.3M | 92,397 | +0.16pp | 19q | HELD | |
| TRANSUNION | TRU | $3.2M | 44,595 | +0.01pp | 14q | HELD | |
| REVOLUTION MEDICINES INC | RVMD | $3.2M | 16,994 | +0.27pp | 4q | -18.3%-$715.2K | |
| DATADOG INC | DDOG | $3.1M | 12,000 | - | new | NEW | |
| BRIDGEBIO PHARMA INC | BBIO | $3.0M | 39,742 | -0.19pp | 6q | -19.3%-$709.6K | |
| WINGSTOP INC | WING | $2.9M | 17,000 | +0.26pp | 5q | +41.7%+$867.0K | |
| INTERCONTINENTAL EXCHANGE IN | ICE | $2.9M | 23,913 | -0.22pp | 22q | HELD | |
| ECHOSTAR CORP | ECHO | $2.8M | 27,509 | +0.32pp | 2q | +119.9%+$1.5M | |
| VERTIV HOLDINGS CO | VRT | $2.8M | 8,286 | +0.04pp | 5q | -18.2%-$616.4K | |
| ABSCI CORPORATION | ABSI | $2.8M | 237,764 | +0.50pp | 3q | HELD | |
| ZYMEWORKS INC | ZYME | $2.7M | 105,184 | +0.01pp | 15q | HELD | |
| MOTOROLA SOLUTIONS INC | MSI | $2.6M | 6,302 | -0.05pp | 3q | HELD | |
| MBX BIOSCIENCES INC | MBX | $2.4M | 43,597 | +0.26pp | 8q | HELD | |
| BOOKING HOLDINGS INC | BKNG | $2.2M | 12,500 | +0.02pp | 30q | +2400.0%+$2.1M | |
| ANALOG DEVICES INC | ADI | $2.2M | 5,485 | - | new | NEW | |
| PROQR THRAPEUTICS N V | PRQR | $2.2M | 1,159,428 | +0.03pp | 7q | -6.2%-$141.5K | |
| NETFLIX INC | NFLX | $2.1M | 30,000 | -0.69pp | 2q | -40.0%-$1.4M | |
| SERVICENOW INC | NOW | $2.0M | 20,000 | - | new | NEW | |
| DOORDASH INC | DASH | $1.8M | 10,000 | - | new | NEW | |
| C4 THERAPEUTICS INC | CCCC | $1.8M | 384,766 | +0.19pp | 2q | HELD | |
| PALO ALTO NETWORKS INC | PANW | $1.6M | 4,766 | - | new | NEW | |
| WAVE LIFE SCIENCES LTD | WVE | $1.6M | 275,269 | -0.11pp | 31q | HELD | |
| IDEXX LABS INC | IDXX | $1.5M | 2,900 | -0.05pp | 5q | -3.3%-$52.6K | |
| BRIGHT MINDS BIOSCIENCES INC | DRUG | $1.3M | 19,127 | -0.02pp | 6q | HELD | |
| STOKE THERAPEUTICS INC | STOK | $1.3M | 40,815 | -0.01pp | 4q | HELD | |
| M-TRON INDS INC | MPTI | $1.3M | 12,839 | - | new | NEW | |
| COSTAR GROUP INC | CSGP | $1.1M | 40,000 | -0.51pp | 10q | -48.4%-$1.1M | |
| A10 NETWORKS INC | ATEN | $1.1M | 28,630 | - | new | NEW | |
| BLOCK INC | XYZ | $950.0K | 12,500 | - | new | NEW | |
| AURA BIOSCIENCES INC | AURA | $794.2K | 111,865 | +0.01pp | 11q | HELD | |
| JD.COM INC | JD | $730.0K | 28,650 | -0.03pp | 31q | HELD | |
| ZOETIS INC | ZTS | $718.6K | 10,000 | -1.07pp | 10q | -76.2%-$2.3M | |
| S&P GLOBAL INC | SPGI | $686.2K | 1,685 | - | new | NEW | |
| ADC THERAPEUTICS SA | ADCT | $622.3K | 581,609 | -0.78pp | 9q | -41.3%-$437.8K | |
| CODEXIS INC | CDXS | $597.7K | 264,464 | +0.04pp | 10q | HELD | |
| INHIBRX BIOSCIENCES INC | INBX | $582.3K | 6,146 | - | new | NEW | |
| ALIBABA GROUP HLDG LTD | BABA | $411.1K | 4,283 | -0.03pp | 31q | HELD | |
| SKYE BIOSCIENCE INC | SKYE | $161.6K | 233,095 | flat | 8q | HELD |
By sector
Industry comes from the SIC code on each company's own SEC filings, which is self-reported and sometimes out of date. Derivative exposure is counted with the shares. Securities the SEC assigns no industry - funds, trusts, foreign issues - are shown as not classified rather than dropped.
| Sector | Value | Share |
|---|---|---|
| Biotech & Pharma | $117.4M | 28.9% |
| Retail & Consumer | $55.0M | 13.5% |
| Semiconductors & Electronics | $52.7M | 12.9% |
| Transport & Logistics | $46.9M | 11.5% |
| Business Services | $40.6M | 10.0% |
| Industrials | $24.9M | 6.1% |
| Software & IT Services | $22.2M | 5.5% |
| Capital Markets | $12.9M | 3.2% |
| Telecom & Media | $9.7M | 2.4% |
| Other sectors | $24.5M | 6.0% |
Quarter by quarter
| Quarter | Value | Positions | New | Added | Trimmed | Exited | Top 10 | Days to file |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | $406.7M | 85 | 10 | 10 | 22 | 14 | 38.9% | 44 |
| Q1 2026 | $396.8M | 89 | 7 | 15 | 30 | 42 | 37.5% | 44 |
| Q4 2025 | $432.7M | 124 | 22 | 8 | 84 | 18 | 36.6% | 44 |
| Q3 2025 | $1.5B | 120 | 15 | 26 | 59 | 10 | 51.7% | 44 |
| Q2 2025 | $1.5B | 115 | 16 | 27 | 47 | 16 | 51.9% | 21 |
| Q1 2025 | $1.7B | 115 | 15 | 46 | 30 | 15 | 64.9% | 45 |
| Q4 2024 | $1.7B | 115 | 18 | 28 | 52 | 25 | 66.1% | 42 |
| Q3 2024 | $2.2B | 122 | 15 | 19 | 60 | 27 | 64.7% | 39 |
| Q2 2024 | $2.5B | 134 | 9 | 31 | 65 | 14 | 64.0% | 44 |
| Q1 2024 | $2.5B | 139 | 15 | 29 | 61 | 18 | 64.8% | 43 |
| Q4 2023 | $2.5B | 142 | 15 | 42 | 40 | 17 | 59.5% | 44 |
| Q3 2023 | $2.6B | 144 | 17 | 40 | 51 | 16 | 59.3% | 34 |
| Q2 2023 | $2.9B | 143 | 16 | 38 | 35 | 19 | 54.7% | 42 |
| Q1 2023 | $2.9B | 146 | 25 | 37 | 51 | 11 | 59.2% | 42 |
| Q4 2022 | $2.6B | 132 | 16 | 44 | 35 | 15 | 60.6% | 44 |
| Q3 2022 | $2.4B | 131 | 9 | 34 | 39 | 8 | 61.8% | 45 |
| Q2 2022 | $2.6B | 130 | 10 | 53 | 31 | 15 | 60.5% | 42 |
| Q1 2022 | $3.3B | 135 | 10 | 32 | 32 | 19 | 60.1% | 43 |
| Q4 2021 | $3.6B | 144 | 12 | 40 | 34 | 14 | 58.0% | 42 |
| Q3 2021 | $3.6B | 146 | 18 | 37 | 53 | 17 | 58.3% | 40 |
| Q2 2021 | $4.3B | 145 | 15 | 44 | 34 | 12 | 53.3% | 42 |
| Q1 2021 | $4.5B | 142 | 14 | 35 | 60 | 18 | 55.7% | 43 |
| Q4 2020 | $4.4B | 146 | 12 | 32 | 59 | 12 | 52.9% | 43 |
| Q3 2020 | $4.0B | 146 | 37 | 25 | 44 | 14 | 52.6% | 44 |
| Q2 2020 | $4.4B | 123 | 17 | 26 | 43 | 10 | 55.9% | 37 |
| Q1 2020 | $4.0B | 116 | 24 | 37 | 33 | 5 | 53.1% | 45 |
| Q4 2019 | $5.0B | 97 | 9 | 22 | 22 | 11 | 56.5% | 44 |
| Q3 2019 | $4.5B | 99 | 9 | 21 | 22 | 7 | 56.7% | 45 |
| Q2 2019 | $4.3B | 97 | 6 | 24 | 25 | 9 | 54.2% | 45 |
| Q1 2019 | $4.2B | 100 | 11 | 24 | 16 | 2 | 49.4% | 45 |
| Q4 2018 | $3.0B | 91 | 0 | 0 | 0 | 0 | 56.9% | 45 |
Rows marked UNVERIFIED ID, PLACEHOLDER ID, TICKER AS ID or NON-CUSIP ID carry an identifier that is not a valid CUSIP. They are shown because the filer reported that money, but treat the security named with caution - hover the chip for what is wrong with it, and see the methodology.
Held counts consecutive filings in which this manager reported the position, and can reach further back than the quarters listed above: the tabs begin at Q4 2018 because earlier coverage is too sparse to describe a market, but tenure is counted over every filing we hold, some reaching to 2007. A position sold and later rebought starts again from one.
Weight change is the shift in this position's share of the whole book, in percentage points. It is the more useful column: when money flows into or out of a broad fund, almost every holding is bought or sold at once, so added and trimmed largely track flows. A weight that rose while the book shrank is a decision. Both compare with the previous quarter this filer reported, not the previous calendar quarter.